Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002561184 | SCV001376678 | likely benign | Dyskeratosis congenita, autosomal dominant 2; Idiopathic Pulmonary Fibrosis | 2023-04-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004559926 | SCV002695462 | uncertain significance | Dyskeratosis congenita | 2022-10-11 | criteria provided, single submitter | clinical testing | The p.P431L variant (also known as c.1292C>T), located in coding exon 2 of the TERT gene, results from a C to T substitution at nucleotide position 1292. The proline at codon 431 is replaced by leucine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |